BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230202
DTEND;VALUE=DATE:20230203
DTSTAMP:20260516T051006
CREATED:20221208T120155Z
LAST-MODIFIED:20221208T120155Z
UID:36005-1675296000-1675382399@www.pharmajournalist.com
SUMMARY:Cancer Neoantigen Vaccines
DESCRIPTION:Over the last few decades\, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today\, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where are we going? \nJoin us through a series of inspiring keynote presentations and engaging panel discussions to connect with top pioneers in the space\, to discuss the future of cancer immunotherapy and how neoantigens are transforming the field. \nUnlock the new era of vaccine development at Cancer Neoantigen Vaccines\, a 1-day digital conference taking place February 2\, 2023 and discover the path to commercial success with novel approaches toward cancer neoantigen vaccines. \nYou’ll shape the future of next generation cancer vaccine development with new oncolytic approaches and critical immunotherapy strategies and uncover\, key research on targets and evolution\, how to successfully enter global markets and the future of personalisation and beyond. \nYou can expect to uncover methods of identifying true targets and deep dive into the future of machine and deep learning in identifying neoantigens. Plus\, you’ll hear successful case studies and promising data on the latest neoantigen vaccine development and gain a deeper understanding of the future of vaccines in personalised medicine. Don’t miss your opportunity to be a part of the discussions with industry experts on their look to the future. \nAll of this plus much more without leaving your desk! Your digital pass gives you access to the full attendee list with video chat\, instant message\, and meeting request functionalities to connect with like-minded thought-leaders in the field to expand your network\, and access to the content on-demand for 10 working days post-event.
URL:https://www.pharmajournalist.com/event/cancer-neoantigen-vaccines/
LOCATION:Digital Conference
ORGANIZER;CN="Informa Connect":MAILTO:Danielle.horney@informa.com
END:VEVENT
END:VCALENDAR